Statins and the kidney: friend or foe?
- 1 March 2015
- journal article
- editorial
- Published by Elsevier BV in The Lancet Diabetes & Endocrinology
- Vol. 3 (3), 161-162
- https://doi.org/10.1016/s2213-8587(14)70260-8
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trialThe Lancet Diabetes & Endocrinology, 2015
- Rosuvastatin-Induced Acute Interstitial NephritisCase Reports in Nephrology and Dialysis, 2013
- Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databasesBMJ, 2013
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet, 2011
- Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trialsBMJ, 2008
- Effect of Intensive Lipid Lowering with Atorvastatin on Renal Function in Patients with Coronary Heart DiseaseClinical Journal of the American Society of Nephrology, 2007
- HMG-CoA reductase inhibitors and the kidneyKidney International, 2007
- RosuvastatinAmerican Journal of Cardiovascular Drugs, 2004
- Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL StudyDiabetes Care, 2003
- A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney diseaseAmerican Journal of Kidney Diseases, 2003